4.7 Article

Therapeutic role of N-acetyl cysteine (NAC) for the treatment and/or management of SARS-CoV-2-induced lung damage in hamster model

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biotechnology & Applied Microbiology

Key benefits of dexamethasone and antibody treatment in COVID-19 hamster models revealed by single-cell transcriptomics

Emanuel Wyler et al.

Summary: This study investigated the effects of dexamethasone and anti-SARS-CoV-2 antibodies on COVID-19 treatment. Dexamethasone exhibited strong anti-inflammatory properties and prevented severe disease outbreaks. Anti-SARS-CoV-2 antibody treatment reduced pulmonary viral burden. Combination therapy showed additive benefits in both antiviral and anti-inflammatory effects.

MOLECULAR THERAPY (2022)

Article Chemistry, Multidisciplinary

A comparison of Remdesivir versus gold cluster in COVID-19 animal model: A better therapeutic outcome of gold cluster

Zhesheng He et al.

Summary: Gold clusters show better therapeutic outcomes in COVID-19 treatment than Remdesivir, as they directly inhibit viral replication and suppress inflammatory cytokine expression.

NANO TODAY (2022)

Article Infectious Diseases

Differential susceptibility of SARS-CoV-2 in animals: Evidence of ACE2 host receptor distribution in companion animals, livestock and wildlife by immunohistochemical characterisation

Fabian Z. X. Lean et al.

Summary: ACE2 serves as the receptor for coronaviruses and shows varied distribution in different animal tissues, affecting host susceptibility. The presence of ACE2 in the respiratory tract varies among species, providing insights into the receptor-mediated viral infection.

TRANSBOUNDARY AND EMERGING DISEASES (2022)

Review Medicine, General & Internal

COVID-19: Current understanding of its Pathophysiology, Clinical presentation and Treatment

Anant Parasher

Summary: COVID-19, caused by the novel coronavirus SARS-CoV-2, has rapidly spread globally and presents in a spectrum of mild, moderate, and severe illness. Diagnosis is currently based on reverse-transcription PCR of nasopharyngeal and oropharyngeal swab samples, with treatment including ventilation, antipyretics, antivirals, antibiotics, and steroids.

POSTGRADUATE MEDICAL JOURNAL (2021)

Article Virology

Vascular Inflammation Is Associated with Loss of Aquaporin 1 Expression on Endothelial Cells and Increased Fluid Leakage in SARS-CoV-2 Infected Golden Syrian Hamsters

Lisa Allnoch et al.

Summary: The study found that SARS-CoV-2 infection causes endothelial hypertrophy, endothelialitis, and vasculitis, with inflammation mainly consisting of macrophages and fewer T-lymphocytes and neutrophils/heterophils infiltrating vascular walls. Affected vessels exhibit edema formation associated with loss of aquaporin 1 on endothelial cells.

VIRUSES-BASEL (2021)

Review Critical Care Medicine

Interleukin-6 receptor blockade in patients with COVID-19: placing clinical trials into context

Federico Angriman et al.

Summary: The studies on IL-6 receptor antagonists show clinical and methodological heterogeneity, which may have led to apparently inconsistent results due to factors such as timing from clinical presentation to treatment, severity of illness, and concomitant use of corticosteroids.

LANCET RESPIRATORY MEDICINE (2021)

Article Immunology

Vasculitis and Neutrophil Extracellular Traps in Lungs of Golden Syrian Hamsters With SARS-CoV-2

Kathrin Becker et al.

Summary: Neutrophil extracellular traps (NETs) play a crucial role in severe COVID-19 cases, and the Syrian hamster model could serve as a useful tool to further investigate the impact of vascular lesions and NETs in the pathogenesis of COVID-19.

FRONTIERS IN IMMUNOLOGY (2021)

Article Biochemistry & Molecular Biology

Quantitative proteomics of hamster lung tissues infected with SARS-CoV-2 reveal host factors having implication in the disease pathogenesis and severity

Voddu Suresh et al.

Summary: This study confirmed the infectivity of a local SARS-CoV-2 isolate in a hamster model, showing similar lung pathology to COVID-19 patients and other hamsters. The lung-associated pathological changes were prominent on the 4th day post-infection and mostly resolved by 14 dpi. Proteomic analysis identified 68 significantly altered proteins between infected groups, with highlighted pathways including complement and coagulation cascade, platelet activation, ferroptosis, and focal adhesion. Additionally, altered expression of pulmonary surfactant-associated proteins Sftpd and Sftpb was observed, suggesting their potential role in SARS-CoV-2 pathogenesis and disease progression.

FASEB JOURNAL (2021)

Article Multidisciplinary Sciences

In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains

Rita E. Chen et al.

Summary: Cell culture experiments showed reduced or abrogated neutralizing activity of monoclonal antibodies against SARS-CoV-2 variant strains, but low prophylactic doses of antibody combinations protected against infection in vivo without resistance emergence. Higher doses of several monoclonal antibody cocktails also provided protection against viruses with a B.1.351 spike gene in vivo. Many antibody products with Emergency Use Authorization should therefore retain substantial efficacy against prevailing variant strains of SARS-CoV-2.

NATURE (2021)

Article Microbiology

SARS-CoV-2 infection in the Syrian hamster model causes inflammation as well as type I interferon dysregulation in both respiratory and non-respiratory tissues including the heart and kidney

Magen Ellen Francis et al.

Summary: COVID-19 is a disease caused by SARS-CoV-2 infection that affects multiple organ systems, including the respiratory tract, urinary tract, neurological system, and cardiovascular system. Understanding the host immune responses in these systems is crucial for studying the disease and potential therapies. Inflammatory cytokines were increased while type I interferons were inhibited, indicating the complex immune responses contributing to multiorgan disease in COVID-19 patients and potentially in those with post-acute sequelae of SARS-CoV-2.

PLOS PATHOGENS (2021)

Article Infectious Diseases

N-acetyl-cysteine reduces the risk for mechanical ventilation and mortality in patients with COVID-19 pneumonia: a two-center retrospective cohort study

Stelios F. Assimakopoulos et al.

Summary: Oral NAC administration reduces the risk of progression to severe respiratory failure and mortality in patients with COVID-19 pneumonia. NAC significantly decreases 14- and 28-day mortality in severe disease patients.

INFECTIOUS DISEASES (2021)

Article Biochemistry & Molecular Biology

SARS-CoV2 infection impairs the metabolism and redox function of cellular glutathione

Desiree Bartolini et al.

Summary: This study found that SARS-CoV2 infection impairs cellular glutathione metabolism, leading to a decrease in GSH levels. Treatment with NAC and the antiviral drug Nel can prevent this defect.

REDOX BIOLOGY (2021)

Article Immunology

N-Acetylcysteine as Adjuvant Therapy for COVID-19-A Perspective on the Current State of the Evidence

Kon Ken Wong et al.

Summary: N-acetylcysteine, as a precursor of the important antioxidant glutathione, has shown potential as an adjunctive therapy in respiratory viral infections, including COVID-19. In vitro and in vivo studies have demonstrated its ability to increase antioxidant capacity, interfere with virus replication, and modulate the immune response, suggesting it may be a promising treatment option for severe cases of COVID-19.

JOURNAL OF INFLAMMATION RESEARCH (2021)

Review Pathology

COVID-19 Vasculopathy: Mounting Evidence for an Indirect Mechanism of Endothelial Injury

Roberto F. Nicosia et al.

Summary: Critically ill COVID-19 patients develop vascular complications characterized by thrombosis in blood vessels of various sizes. Dysfunction of the vascular endothelium is mainly due to the indirect effects of the virus through cytokine storms and excessive immune response, rather than direct viral entry and infection of endothelial cells.

AMERICAN JOURNAL OF PATHOLOGY (2021)

Article Immunology

Beneficial effect of combinational methylprednisolone and remdesivir in hamster model of SARS-CoV-2 infection

Zi-Wei Ye et al.

Summary: Research shows that methylprednisolone alone and in combination with remdesivir have beneficial effects in the hamster model of SARS-CoV-2 infection, preventing weight loss, inflammation, and reducing viral loads. Combining anti-inflammatory and antiviral therapy may offer a more effective and safer treatment option for COVID-19, supporting further clinical trials to test the efficacy of methylprednisolone and remdesivir combination therapy.

EMERGING MICROBES & INFECTIONS (2021)

Letter Medicine, General & Internal

On the use of corticosteroids for 2019-nCoV pneumonia

Lianhan Shang et al.

LANCET (2020)

Article Medicine, Research & Experimental

Clinical and immunological features of severe and moderate coronavirus disease 2019

Guang Chen et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

Article Medicine, Research & Experimental

N-Acetylcysteine: A potential therapeutic agent for SARS-CoV-2

Francis L. Poe et al.

MEDICAL HYPOTHESES (2020)

Article Medicine, General & Internal

Remdesivir for the Treatment of Covid-19-Final Report

John H. Beigel et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Biochemistry & Molecular Biology

Rationale for the use ofN-acetylcysteine in both prevention and adjuvant therapy of COVID-19

Silvio De Flora et al.

FASEB JOURNAL (2020)

Editorial Material Medicine, General & Internal

Is a Cytokine Storm Relevant to COVID-19?

Pratik Sinha et al.

JAMA INTERNAL MEDICINE (2020)

Article Multidisciplinary Sciences

Favipiravir at high doses has potent antiviral activity in SARS-CoV-2-infected hamsters, whereas hydroxychloroquine lacks activity

Suzanne J. F. Kaptein et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Review Biochemistry & Molecular Biology

COVID-19 and Oxidative Stress

B. Chernyak et al.

BIOCHEMISTRY-MOSCOW (2020)

Review Health Care Sciences & Services

N-Acetylcysteine to Combat COVID-19: An Evidence Review

Zhongcheng Shi et al.

THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2020)

Review Biochemistry & Molecular Biology

Medical and Dietary Uses of N-Acetylcysteine

Spela Salamon et al.

ANTIOXIDANTS (2019)

Article Physiology

Oral N-acetylcysteine and exercise tolerance in mild chronic obstructive pulmonary disease

Daniel M. Hirai et al.

JOURNAL OF APPLIED PHYSIOLOGY (2017)

Article Chemistry, Multidisciplinary

Intraperitoneal N-acetylcysteine for acute iron intoxication in rats

Rachelle Breitbart et al.

DRUG AND CHEMICAL TOXICOLOGY (2011)

Article Immunology

N-acetylcysteine synergizes with oseltamivir in protecting mice from lethal influenza infection

A. Garozzo et al.

INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2007)

Article Pharmacology & Pharmacy

Impact of 30-day oral dosing with N-acetyl-L-cysteine on Sprague-Dawley rat physiology

DP Arfsten et al.

INTERNATIONAL JOURNAL OF TOXICOLOGY (2004)